Charles River Laboratories (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 1,363,302 | 1,297,662 | 1,165,528 | 1,129,530 | 1,142,647 |
| Cost of Goods | 832,210 | 825,002 | 770,626 | 737,449 | 740,405 |
| Gross Profit | 531,092 | 472,660 | 394,902 | 392,081 | 402,242 |
| Operating Expenses | 324,853 | 294,992 | 244,127 | 226,765 | 228,341 |
| Operating Income | 206,449 | 177,670 | 151,401 | 165,765 | 174,306 |
| Interest Expense | 15,072 | 11,950 | 20,969 | 33,342 | 42,586 |
| Other Income | 4,051 | 11,875 | 7,895 | -2,677 | 942 |
| Pre-tax Income | 195,428 | 177,595 | 138,327 | 129,746 | 132,662 |
| Income Tax | 43,391 | 47,671 | 32,911 | 27,628 | 17,140 |
| Net Income Continuous | 152,037 | 129,924 | 105,416 | 102,118 | 115,522 |
| Net Income Discontinuous | -950 | -1,726 | -1,265 | -4,252 | -5,545 |
| Minority Interests | 1,774 | 1,500 | 1,323 | 571 | 411 |
| Net Income | $149,313 | $126,698 | $102,828 | $97,295 | $109,566 |
| EPS Basic Total Ops | 3.21 | 2.72 | 2.15 | 2.03 | 2.16 |
| EPS Basic Continuous Ops | 3.23 | 2.76 | 2.18 | 2.12 | 2.26 |
| EPS Basic Discontinuous Ops | -0.02 | -0.04 | -0.03 | -0.09 | -0.11 |
| EPS Diluted Total Ops | 3.13 | 2.66 | 2.12 | 2.01 | 2.14 |
| EPS Diluted Continuous Ops | 3.15 | 2.70 | 2.15 | 2.10 | 2.24 |
| EPS Diluted Discontinuous Ops | -0.02 | -0.04 | -0.03 | -0.09 | -0.11 |
| EBITDA(a) | $301,330 | $275,840 | $257,598 | $264,662 | $279,546 |